Northern Trust’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $839M | Sell |
13,373,881
-561,542
| -4% | -$44.9M | 0.11% | 164 |
|
|
2025
Q4 | $1.33B | Sell |
13,935,423
-467,213
| -3% | -$45.8M | 0.17% | 106 |
|
|
2025
Q3 | $1.41B | Buy |
14,402,636
+128,188
| +0.9% | +$13.3M | 0.18% | 102 |
|
|
2025
Q2 | $1.53B | Sell |
14,274,448
-28,176
| -0.2% | -$2.85M | 0.21% | 85 |
|
|
2025
Q1 | $1.44B | Sell |
14,302,624
-293,003
| -2% | -$29.5M | 0.21% | 87 |
|
|
2024
Q4 | $1.3B | Buy |
14,595,627
+2,221,790
| +18% | +$196M | 0.18% | 95 |
|
|
2024
Q3 | $1.04B | Sell |
12,373,837
-529,752
| -4% | -$41.8M | 0.17% | 112 |
|
|
2024
Q2 | $994M | Sell |
12,903,589
-155,362
| -1% | -$11.4M | 0.17% | 110 |
|
|
2024
Q1 | $894M | Sell |
13,058,951
-683,054
| -5% | -$43.9M | 0.15% | 127 |
|
|
2023
Q4 | $794M | Sell |
13,742,005
-148,525
| -1% | -$7.93M | 0.14% | 134 |
|
|
2023
Q3 | $733M | Buy |
13,890,530
+531,914
| +4% | +$27.9M | 0.14% | 133 |
|
|
2023
Q2 | $723M | Sell |
13,358,616
-438,876
| -3% | -$22.9M | 0.14% | 134 |
|
|
2023
Q1 | $690M | Sell |
13,797,492
-80,036
| -0.6% | -$3.77M | 0.14% | 144 |
|
|
2022
Q4 | $642M | Buy |
13,877,528
+37,041
| +0.3% | +$1.6M | 0.13% | 155 |
|
|
2022
Q3 | $536M | Sell |
13,840,487
-90,940
| -0.7% | -$3.65M | 0.12% | 160 |
|
|
2022
Q2 | $519M | Buy |
13,931,427
+64,171
| +0.5% | +$2.61M | 0.11% | 175 |
|
|
2022
Q1 | $614M | Buy |
13,867,256
+45,404
| +0.3% | +$1.97M | 0.11% | 167 |
|
|
2021
Q4 | $587M | Sell |
13,821,852
-106,995
| -0.8% | -$4.5M | 0.1% | 187 |
|
|
2021
Q3 | $604M | Sell |
13,928,847
-82,570
| -0.6% | -$3.65M | 0.11% | 169 |
|
|
2021
Q2 | $599M | Sell |
14,011,417
-301,099
| -2% | -$12.7M | 0.11% | 170 |
|
|
2021
Q1 | $553M | Sell |
14,312,516
-236,877
| -2% | -$8.97M | 0.1% | 177 |
|
|
2020
Q4 | $523M | Sell |
14,549,393
-640,664
| -4% | -$23.1M | 0.1% | 172 |
|
|
2020
Q3 | $580M | Buy |
15,190,057
+31,044
| +0.2% | +$1.2M | 0.13% | 152 |
|
|
2020
Q2 | $532M | Sell |
15,159,013
-63,034
| -0.4% | -$2.27M | 0.13% | 153 |
|
|
2020
Q1 | $497M | Sell |
15,222,047
-84,460
| -0.6% | -$3.3M | 0.14% | 143 |
|
|
2019
Q4 | $692M | Sell |
15,306,507
-512,560
| -3% | -$21.4M | 0.15% | 130 |
|
|
2019
Q3 | $644M | Buy |
15,819,067
+21,044
| +0.1% | +$892K | 0.15% | 131 |
|
|
2019
Q2 | $679M | Sell |
15,798,023
-33,084
| -0.2% | -$1.27M | 0.16% | 122 |
|
|
2019
Q1 | $608M | Buy |
15,831,107
+300,231
| +2% | +$11.5M | 0.15% | 134 |
|
|
2018
Q4 | $549M | Buy |
15,530,876
+596,703
| +4% | +$21.6M | 0.15% | 129 |
|
|
2018
Q3 | $575M | Sell |
14,934,173
-68,010
| -0.5% | -$2.38M | 0.14% | 137 |
|
|
2018
Q2 | $491M | Buy |
15,002,183
+36,565
| +0.2% | +$1.1M | 0.12% | 163 |
|
|
2018
Q1 | $409M | Sell |
14,965,618
-195,059
| -1% | -$5.3M | 0.11% | 190 |
|
|
2017
Q4 | $376M | Sell |
15,160,677
-231,824
| -2% | -$6.39M | 0.1% | 214 |
|
|
2017
Q3 | $449M | Buy |
15,392,501
+929,645
| +6% | +$25.7M | 0.12% | 172 |
|
|
2017
Q2 | $401M | Sell |
14,462,856
-66,672
| -0.5% | -$1.77M | 0.11% | 181 |
|
|
2017
Q1 | $361M | Buy |
14,529,528
+80,315
| +0.6% | +$1.95M | 0.1% | 191 |
|
|
2016
Q4 | $313M | Sell |
14,449,213
-176,283
| -1% | -$3.85M | 0.1% | 208 |
|
|
2016
Q3 | $348M | Buy |
14,625,496
+145,621
| +1% | +$3.47M | 0.11% | 192 |
|
|
2016
Q2 | $338M | Buy |
14,479,875
+552,807
| +4% | +$12M | 0.11% | 188 |
|
|
2016
Q1 | $261M | Buy |
13,927,068
+46,106
| +0.3% | +$810K | 0.09% | 230 |
|
|
2015
Q4 | $256M | Sell |
13,880,962
-997,491
| -7% | -$17.9M | 0.08% | 232 |
|
|
2015
Q3 | $244M | Sell |
14,878,453
-531,828
| -3% | -$9.09M | 0.08% | 245 |
|
|
2015
Q2 | $273M | Sell |
15,410,281
-45,967
| -0.3% | -$821K | 0.08% | 238 |
|
|
2015
Q1 | $274M | Sell |
15,456,248
-435,770
| -3% | -$6.89M | 0.08% | 247 |
|
|
2014
Q4 | $211M | Buy |
15,892,018
+617,386
| +4% | +$7.89M | 0.06% | 303 |
|
|
2014
Q3 | $180M | Sell |
15,274,632
-1,371,234
| -8% | -$17.3M | 0.06% | 316 |
|
|
2014
Q2 | $213M | Sell |
16,645,866
-346,539
| -2% | -$4.51M | 0.07% | 278 |
|
|
2014
Q1 | $230M | Sell |
16,992,405
-135,450
| -0.8% | -$1.78M | 0.07% | 269 |
|
|
2013
Q4 | $206M | Sell |
17,127,855
-95,126
| -0.6% | -$1.12M | 0.07% | 285 |
|
|
2013
Q3 | $202M | Sell |
17,222,981
-527,716
| -3% | -$5.71M | 0.07% | 273 |
|
|
2013
Q2 | $165M | Buy |
+17,750,697
| New | +$151M | 0.06% | 321 |
|
Other funds holding BSX
VCM
VPM
Northern Trust's BSX Position: Q1 2026 in Review
Northern Trust reduced its Boston Scientific (BSX) stake by 4% in Q1 2026, selling an estimated $44.9M and leaving 13,373,881 shares worth $839M. The position accounts for 0.11% of the portfolio, ranked #164.
Northern Trust first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.53B in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Northern Trust held 13,373,881 shares of Boston Scientific worth $839M as of Q1 2026.
- Northern Trust sold 561,542 Boston Scientific shares in Q1 2026, an estimated $44.9M.
- Boston Scientific made up 0.11% of Northern Trust's portfolio in Q1 2026, its #164 holding.
- Northern Trust first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Boston Scientific position peaked at $1.53B in Q2 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.